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Abstract  
 
Objectives: 82% of HIV-positive adolescents live in sub-Saharan Africa (SSA). 
Despite the availability of antiretroviral therapy (ART), adherence levels are 
suboptimal, leading to poor outcomes. This systematic review investigated factors 
impacting ART adherence among adolescents in SSA, including religious beliefs and 
intimate relationships.  
Methods: A systematic review was conducted between June and August 2016 using 
eight electronic databases, including Cochrane and PubMed. Published, ongoing 
and unpublished research, conducted in SSA from 2004 to 2016, was identified and 
thematic analysis was used to summarise findings.    
Results: Eleven studies from eight SSA countries, published in English between 
2011 and 2016, reported on factors impacting ART adherence among adolescents 
living with HIV (ALHIV). 44 barriers and 29 facilitators to adherence were identified, 
representing a complex web of factors. The main barriers were stigma, ART side-
effects, lack of assistance and forgetfulness. Facilitators included caregiver support, 
peer support groups and knowledge of HIV status. 
Conclusions: Stigma reflects difficult relations between ALHIV and their HIV-
negative peers and adults. Most interventions target only those with HIV, suggesting 
a policy shift towards the wider community could be beneficial. Recommendations 
include engaging religious leaders and schools to change negative societal attitudes. 
Limitations of the review include the urban settings and recruitment of predominantly 
vertically infected participants in most included studies. Therefore, the findings 
cannot be extrapolated to ALHIV residing in rural locations or horizontally infected 
ALHIV, highlighting the need for further research in those areas. 
Key words: HIV, adolescents, sub-Saharan Africa, antiretroviral therapy, adherence 
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Introduction  
Acquired immunodeficiency syndrome (AIDS) is the main reason for death in African 
adolescents aged 10 to 19 years.1 Out of 2.0 million human immunodeficiency virus 
(HIV) positive adolescents worldwide, 82% live in sub-Saharan Africa (SSA).2 
Adolescents acquire HIV either vertically from their mother or horizontally through 
sexual contact or risky behaviour.3  
Although still incurable, HIV in SSA has changed from a ‘killer disease’ to a 
treatable chronic condition since paediatric antiretroviral therapy (ART) was 
introduced in SSA in 2004,4 leading to great improvements in survival and life quality 
among adolescents.5 But effective treatment outcomes depend on optimal ART 
adherence,6 where adherence refers to an individual’s capability to take drugs at 
recommended times.7 In addition, ART dramatically reduces rates of onward HIV 
transmission.8 Public health strategies today are building on this to contain the 
epidemic. All HIV-positive pregnant women are given ART to prevent infection of 
babies.9 Countries are introducing ‘Test and Treat’ policies where all patients testing 
HIV-positive immediately start treatment.9 But low infectivity depends on optimal ART 
adherence, classified as at least 95% of doses expected to be used.10 Poor ART 
adherence can lead to treatment failure, disease progression, increased risk of 
transmission11 and health care costs.12,13  
According to Gulick,14 adherence varies over time, making frequent 
adherence assessments crucial. Assessments are performed either subjectively 
through patient or caregiver reports; or objectively: pharmacologically through pill 
count or electronic measurement, physiologically through viral load tests. All 
methods have limitations and can lead to inaccurate estimates.15 Pill counts can be 
modified; verbal reports present an easily biased subjective result and frequent viral 
load tests are often unaffordable in developing countries.16 Combining methods 
could improve accuracy.17  
Today, HIV in SSA is a public health challenge: how to get millions of people 
in rural areas with poor health infrastructure to take daily medicines.18 The challenge 
is greatest for adolescents undergoing the physical, social and psychological 
changes of sexual maturity. Being HIV-positive adds to the complexity of difficulties 
faced by this group.19 While data on ART coverage and adherence is limited, 10 
studies suggest less than half of adolescents living with HIV (ALHIV) know their 
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status and that adherence levels are suboptimal.10, 20 One study reported only 20.7% 
of adolescents achieve good adherence.20 ART adherence levels are poorer in 
ALHIV compared to adults.21,22 
The factors impacting ART adherence can be categorised according to the 
patient, the medication, the caregiver and the health system.23 Multiple factors are 
involved which may vary according to age, context, culture, health system, education 
and caregiver support. 24 Some factors may be temporary, others permanent. 
Poverty, stigma, lack of social support, family disintegration, drug side-effects, weak 
health systems, and disclosure of HIV status are cited as impacting adolescent ART 
adherence.25-27 
Disclosure is defined as acquiring knowledge about one’s HIV status28 or 
informing others about one’s HIV status.29 Adolescents who do not know why they 
are taking medicines are more likely to miss doses and those unable to tell their 
family and friends of their HIV status may need to hide their treatment, making 
adherence more difficult.30 Additionally, religious beliefs,31 described as “the belief in 
and worship of a superhuman controlling power”,32 and intimate relationships,33 may 
play a role in ALHIV adhering to ART. Often ALHIV hide poor adherence from 
health-care providers to avoid rejection.34, 35  
With limited resources available, interventions need to be designed to address 
different contexts and continuously evaluated for effectiveness.25 Agwu and Fairlie36 
found that interventions to promote disclosure and counselling facilitate adherence 
among ALHIV. HIV peer support groups were also mentioned as beneficial.37 
However, strategies can only be improved through increased knowledge of the 
factors impacting ART adherence. Huge resources are spent on viral load tests to 
assess adherence clinically, but much less on interventions to address root causes 
of poor adherence.38  
Several systematic reviews have been published regarding this topic for different 
age groups and contexts.39-45 This study differs from previous reviews by including 
both quantitative and qualitative data and exclusively within the SSA context, where 
HIV prevalence is the highest globally.  
This systematic review aims to identify factors that enable and impede ART 
adherence among ALHIV in SSA; to build on the findings of previous reviews it 
includes religious beliefs and intimate relationships as factors impacting ART 
adherence among ALHIV. Additionally, it intends to guide decision makers involved 
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in HIV programmes, service providers, researchers and the general population, 
making recommendations to improve adolescent adherence to ART in SSA.  
 
 
 
Methods 
 
The review was conducted between 3 June and 15 August 2016, as the final 
research project for an online Master in Public Health at the University of 
Hertfordshire, UK. A systematic, all-language search including quantitative and 
qualitative studies that addressed factors impacting ART adherence in SSA ALHIV 
was performed. 
 
Search strategy  
 
Eight electronic databases providing high quality medical publications (Cochrane, 
PubMed, CINHAL Plus, Scopus, Web of Knowledge, TRIP, Science Direct, Google 
Scholar) were searched systematically to identify relevant peer-reviewed articles. All 
searches were conducted directly without using an intermediate interface such as 
Ovid. Databases of ongoing research were included and OpenGrey was searched. 
Relevant publications from reference lists of five articles were retrieved and 
screened for duplications.23,25,40,43,46   
The following keywords and MESH terms were used: HIV, adolescents, sub-
Saharan Africa, antiretroviral therapy, adherence. Alternative keywords for each 
concept were utilised (see Supplementary online resource(s)).  
Search filters included ‘human studies’, ‘the adolescent age group (10-19 
years)’ and studies performed in ‘SSA countries’. Publications from 2004 (when 
paediatric ART was introduced in SSA) to June 2016 were examined. All-language 
studies were included. Children aged less than10 years and adults were excluded. 
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Study selection and eligibility criteria 
 
After removal of duplicates, all titles, abstracts and full-text articles were reviewed by 
one investigator, using pre-defined inclusion and exclusion criteria. Articles and 
abstracts were excluded if they did not address the population, intervention or 
outcome of interest. Potentially eligible studies met the following criteria: (1) used a 
qualitative, quantitative or mixed-methods design, (2) were peer-reviewed original 
studies, (3) were studies conducted after ART induction in SSA in 2004, (4) 
discussed and evaluated an association between ART adherence among ALHIV in 
SSA and at least one patient-related, medication-related, caregiver-related or health 
system-related factor, and (5) displayed good quality, with ethical approval and 
informed participant consent. 
For inclusion, studies needed: adherence to be assessed using pill count, self-
report, caregiver report, viral load result or electronic monitoring; good adherence 
defined as >90%;10 ≥50% participants aged 10 to 19 years. Studies could include 
both vertically- and horizontally- infected ALHIV. Studies on ALHIV were excluded if 
they did not identify factors impacting ART adherence. Before inclusion, cross-
sectional studies were appraised for quality of evidence, using the appraisal tool 
from the National Institutes of Health.47 For qualitative studies, the Critical Appraisal 
Skills Programme (CASP)48 was used. A second reviewer screened and assessed 
the studies independently. Heterogeneity was assessed by including studies with 
same outcome measures and consistency of results. 
 
 
Data extraction and analysis 
 
After identifying final studies, data were extracted using a standard template and 
summarised in tabular form. The data analysis was designed to develop a list in 
word of factors reported as impacting ART adherence in ALHIV in SSA, with 
explanations of how behaviour and attitudes of ALHIV are influenced. Data from 
qualitative studies was extracted using thematic analysis49 with results sorted into 
four main categories: patient-related, medication-related, caregiver-related, and 
health system-related factors.50 These categories were further divided into facilitators 
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and barriers. Quantitative data results were listed under the same headings. Finally, 
findings were recorded according to frequency of topics occurring across studies. 
The Preferred Reporting Items for Systematic Reviews and Meta-Analyses 
(PRISMA) statement51 guided the review protocol. 
 
Study selection process 
 
The literature search yielded 656 potentially relevant studies. After removal of 
duplicates, 75 articles remained; further review of titles and abstracts excluded 45 
articles which did not meet inclusion criteria. The remaining 30 papers were full text 
screened with a focus on studies including religious belief and intimate relationships 
as factors influencing ART adherence, leaving 11 studies which were published in 
English between 2011 and 2016 (research carried out 2007-2014) from eight SSA 
countries. A flow diagram outlining the study selection process is detailed in Figure 
1.  
<Figure 1> 
 
 
Results 
 
 
Study characteristics  
 
Characteristics of the 11 included studies are summarised in Table 1. Study 
countries were Congo (Democratic Republic), Ghana, Kenya, Rwanda, South Africa, 
Uganda, Zambia and Zimbabwe. Seven studies used a qualitative, three a mixed 
methods approach and one a quantitative cross-sectional design. All qualitative 
studies used in-depth interviews, five used focus groups, one role play and one 
participant observation. The quantitative study used a cross-sectional design. 
Additional to the adolescent study participants, seven studies included caregivers, 
three healthcare workers, one community members and one stakeholders.  
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All but one study52 sampled their population purposively. Quantitative 
methods used logistic regression to examine associations and produce odds ratios. 
Eight studies comprised an urban and three both rural and urban clinic setting. 
Qualitative study samples varied from 19 to 42 participants. Despite the fact that 
authors rarely acknowledged their own role in influencing the research, included 
studies were of high methodological quality addressing potential bias. Their results 
were appraised to be valid using recommended tools47,48. Ethical approval was 
obtained by all studies. 
<Table 1> 
Characteristics of study participants  
 
Studies included 3,407 participants broken down as follows: 3,199 adolescents 
(2,999 in quantitative and 200 in qualitative studies); 191 caregivers (parents, non-
parental caregiver, biological relative, non-relative, or foster-carer) and 17 healthcare 
providers. The proportion of female adolescent study participants ranged from 45% 
to 63%. Three studies examined selectively ALHIV aged 10 to 19 years. Two studies 
divided the study population into two age-groups, early (10-14 years) and late 
adolescence (15-19 years). Six studies did not report participant mode of 
transmission, two involved only vertically infected ALHIV and three included majority 
(79%-89%) vertically infected participants. Six studies considered only participants 
who knew their HIV status, two did not specify and in three, the proportion of 
disclosed participants ranged from 20% to 90%. In three studies most participants 
belonged to an HIV support group, whilst in the remaining eight this aspect was 
unreported. Six studies documented adolescents who had lost one (21-45%) or both 
parents (15-78%).  
 
 
ART adherence measurements 
 
Documented adherence levels ranged from 64% to 90%. Non-adherence in the past 
week ranged from 6% to 95%. ART adherence was measured by self-reports in six 
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studies; pill counts in one study. Thresholds for optimal adherence ranged from 
>90% to >95%. Study population duration on ART ranged from 6 months to 6 years. 
One study compared adolescents and caregiver reports, finding only 33% 
concordant. ALHIV reported missing doses more often than their caregivers. In one 
study 95% of ALHIV interviewed reported poor ART adherence at some time.26 
Nabukeera-Barungi et al.37 reported better urban ALHIV adherence levels compared 
to rural.  
 
Factors impacting ART adherence  
 
Seven studies identified both facilitators and barriers impacting ART adherence: one 
focused on the barriers only; one examined the association between knowledge of 
HIV status and adherence; one looked at lived experiences, another the 
psychosocial challenges of ALHIV. The studies found 73 factors impacting ART 
adherence among ALHIV in SSA. Results of the factors in qualitative and 
quantitative studies are presented in order of most emergent reported themes and 
summarised in Table 2. Overall, 44 barriers to ART adherence were reported, with 
most (N=23) patient-related. Twenty-nine facilitators to ART adherence were 
counted; most (N=12) were patient-related. Table 3 summarises the findings, 
highlighting the most emergent factors in their categories. 
Religious beliefs and perceived positive treatment outcomes were described 
as both facilitator and barrier. Two studies explored reasons for ALHIV not revealing 
poor adherence to caregivers and healthcare workers, which included protecting and 
maintaining relations, fear of abuse or being scolded by caregivers and unease with 
medical staff. One study52 found travel time to the clinic did not impact adherence, 
while another53 encountered the opposite. Only two studies discussed the role of 
intimate relationships,37,54 finding that fear of rejection by the partner impacted 
adherence.   
 
 
<Table 2> 
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<Table 3> 
 
 
Discussion 
 
This systematic review identified 11 studies, representing 3,407 participants in eight 
SSA countries.  
The findings evidence a complicated web of factors influencing ALHIV 
adherence. In total, 44 barriers and 29 facilitators were identified. Most were patient-
related, with stigma as the greatest barrier, followed by drug side-effects, 
forgetfulness, lack of caregiver support, not knowing the reason for taking the drugs, 
poverty, and depression. Important factors facilitating adherence were caregiver 
support, peer support groups, knowledge of HIV status, use of reminders, and 
support from healthcare workers. Results concur with existing reviews examining 
different age groups.23,25,43,44 Factors were found to inter-relate and it is important to 
note that an individual’s adherence behaviour is not linear, but changes over 
time.14,55  
Stigma appeared universally as a main barrier to ART adherence. Perceived 
stigma, as a consequence of HIV status disclosure to peers, but also stigma 
experienced within families and schools was repeatedly mentioned.54,56 Frequently, 
ALHIV felt the need to lie that medicines are taken for other conditions, such as 
asthma, because they feared rejection or discrimination.54,57 Often only one 
caregiver was aware of the adolescent’s HIV status. Caregivers frequently reinforced 
the fear of stigma, discouraging disclosure and encouraging taking medicines in 
secret.26,34,57,58 ALHIV reported that taking ART produced feelings of shame and 
anger26 making them feel different to their peers.27,54,58 Disrupting social activities for 
medication intake created fear of unwanted questions and unintended 
disclosure.24,34,58 Multiple participants preferred to delay or miss doses rather than 
being seen by others.24,54,56 Stigma and applying secrecy as a coping strategy 
repeatedly led to incomplete adherence.34,58 Lack of privacy, expressed in the home 
environment,27 was especially reported in boarding schools,37,54 with congested 
accommodation and lack of psychosocial support.59 This link between stigma and 
non-adherence is consistent with the already mentioned narrative review25 in SSA, 
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the review of ALHIV in USA44 as well as the review of adults globally.60 Only one 
small study of 30 ALHIV in Thailand found no quantitative association between 
stigma and ART adherence.61  
ALHIV unaware of their HIV status and taking daily medicines without a 
comprehensible reason, showed consistently poorer adherence.24,26,34,58 ALHIV who 
were suspected of being HIV-positive before disclosure suffered frustration at being 
lied to, which resulted in refusal to take ART.26,27,34 Caregivers often explained late 
disclosure because of fear of revealing their own HIV status54,60 or guilt.28 
Understanding the reason for taking medicines daily and the importance of ART 
convinced ALHIV mostly to adhere.26,34,63 Disclosure before age 12, following World 
Health Organization recommendations,64 was associated with better outcomes.53 
This finding is consistent with multiple SSA studies50,62,65 and two systematic 
reviews30,66 but contrasts with an Indian study in which caregivers expressed no 
difference.67 However, disclosure to older ALHIV was associated with mistrust and 
poorer adherence.53 A positive experience with disclosure acted as motivator, 
enabling children to seek information, express feelings and access support 
groups.26,54 Furthermore, there is a clear link between how ALHIV discover their HIV 
status and their ability to disclose it to others.30       
Depression as barrier to adherence was linked to lack of acceptance of HIV 
status and weak social support,27,56 especially for ALHIV orphans.26,34 Support from 
caregivers and healthcare workers, but also support groups were crucial to accepting 
HIV status and facilitating adherence.27 Reminding ALHIV to take medicine, as 
forgetfulness was mentioned as a major barrier in several studies57,68-70 beside 
emotional support52 helped in maintaining ART adherence. However, non-parental 
caregivers and boarding schools provided a less supportive environment.27 The 
combination of stigma, secrecy and mental health challenges pushes ALHIV to 
emotional distress undermining the ability to adhere and seek support.54 
ART side-effects, mainly nausea and dizziness, were reported as a major 
barrier. Lack of food discouraged ALHIV taking their ART as required.26,34,37 Here, 
nutritional support and change of ART regimen mitigated side-effects. Also, 
education by healthcare workers to warn of potential side-effects was found 
important.37  
After caregiver support, peer support groups ranked highest as a facilitator. 
These provided an environment for sharing experiences and encouragement that did 
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not require secrecy71 and an understanding that ALHIV are not alone.56,58 Support 
groups being effective for other chronic conditions such as diabetes72 helped also in 
reducing HIV-related stigma among South African adults.73  
 
Religious beliefs   
 
Religious beliefs play an important role in SSA.74 In this review, religious beliefs were 
found as facilitating but also impeding adherence to ART among ALHIV. Similarly, a 
study, involving adults in the Democratic Republic of Congo, found that the belief that 
ART was God-created positively impacted adherence while faith-healing had a 
negative impact.75 
Faith in a superhuman power, as reported by studies in this review, helped 
ALHIV gain self-awareness and self-confidence. Prayers as coping strategy were 
mentioned as motivators to overcome challenges.52 Believing brings hope and 
strength to live positively with HIV.76 This finding concurs with other studies. Youth 
aged 14 to 22 in USA77 were found to have better adherence among those with 
higher religious practise. In another study of USA adults78 participants showing good 
ART adherence had faith, as they felt connected to a higher being and it made their 
life meaningful. Also regarding other chronic conditions, spirituality was mentioned as 
a coping strategy for caregivers.77 
But religious belief can also play a negative role. Faith-healing, as a health-
seeking strategy, is mostly practised by Christians and Muslims in SSA; also 
shamans are consulted.79 This practice often leads ALHIV to stop taking their 
ART27,37,58 in the belief of being cured by prayers, or particularly in Ethiopia, the use 
of holy water.80 Braitstein et al.81 found belief of being healed by prayer accounted 
for 9% of children failing to return to the clinic in Kenya. Several studies highlighted 
the disruption of ART after spiritual healing ceremonies in adults in Uganda,82,83 
Tanzania,76,84 Malawi85 and the USA.86  
Additionally, religious fasting was reported as leading to incomplete 
adherence due to changes in eating times, including ART intake, to comply with their 
religious duties.27 An Ethiopian study80 revealed that fasting during Ramadan and 
fasting practices of the Ethiopian Orthodox Church affected ART adherence. 
Similarly, a Nepalese study, which included adults showed that Ramadan and Teej, a 
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Hindu tradition, both negatively impacted ART adherence.87 Conversely a Nigerian 
study of adults found no association between religious fasting and ART adherence,88 
but highlighted the need for dosing time adjustments during fasting periods. Most 
religions do not oblige children, pregnant women or the sick to follow religious 
fasting.85  
Religious belief is a major factor in shaping social attitudes in SSA, including 
attitudes towards ART. Faith-healing and traditional medicine often coexist with clinic 
visits.89 Evidence regarding religious beliefs was largely from the adult population 
due to data availability, highlighting the need for more research in ALHIV. Religious 
belief could be included in counselling sessions, but also involvement of religious 
authorities in HIV programming could improve ART adherence.  
 
 
Intimate relationships   
 
As intimate relations gain importance in late adolescence, these also impact 
attitudes to ART.90 In this review, the obstacles to ART adherence identified included 
the need to disclose,54 against the fear that disclosing one’s HIV status to partners 
would create stigma and rejection.37,54,57 This is consistent with other studies.29,91-93 A 
study of Ugandan ALHIV37 described how non-disclosure to intimate partners led to 
ART defaulting because of the fear of being recognised as HIV-positive. Additionally, 
a study of Nepalese adults showed 17 times more non-adherence among 
participants who have not disclosed their status.87 While one study reported 
participants experienced post-disclosure stigma,27 another54 revealed that 27% of 
participants who disclosed their status to their partners had a positive response. 
Nöstlinger et al.94 found in Kenya and Uganda an ALHIV disclosure rate of 34.3% to 
intimate partners with mostly optimistic outcomes. A study of Ugandan adults, where 
69% of participants disclosed their HIV status to sexual partners, showed that the 
reduced need for secrecy in this group improved adherence behaviour and 
measures to prevent onward transmission.95 These findings suggest some of the 
stigma and fear may be self-imposed or imposed by caregivers. First intimate 
relationships may well not be with other HIV-positive adolescents. Ideally, 
adolescents need to be given the skills, knowledge and confidence to allow them to 
disclose their status to potential partners, before relationships become sexual. 
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Counselling needs to disseminate the link between good adherence and low risk for 
HIV transmission through reduced infectivity. This could decrease fears of ALHIV 
infecting intimate partners.54  
While this link is now at the centre of strategies to treat and contain the 
epidemic, with countries moving to a “Test and Treat” policy, evidence suggests that 
most ALHIV and adults on treatment do not know about the link.96 Indeed, healthcare 
workers may not tell for fear of promoting intercourse without condoms. More 
evidence to evaluate the potential benefit and harm of a campaign to inform ALHIV 
of this link is needed. Furthermore, psychosocial support in case of experienced or 
perceived stigma is important and should be provided in the home environment and 
also in clinical care. Disclosure to intimate partners is crucial for preventing onward 
transmission of HIV.97 Considering the high number of ALHIV not knowing their 
status,98 intimate relationships pose a serious concern for public health. 
 
 
 
Limitations 
 
The strengths of this review derive from the extensive search strategy employed, the 
inclusion of qualitative and quantitative studies which involved adolescents, 
caregivers and service providers to gain a holistic perspective. Additionally, the 
inclusion of unpublished research limited publication bias and the all-language 
consideration minimised language bias. However, limitations also need to be 
acknowledged. First, the inclusion of cross-sectional study designs limits 
corroboration of causal relationships. Second, the subjectivity of qualitative research 
could have caused bias, but the consistent recurrence of factors in the studies 
supports the inference of external validity for the SSA context. However, internal 
validity could have been affected as four studies did not acknowledge the 
researchers’ role in analysis and data selection. It also needs to be noted that some 
reported factors might be culturally specific and therefore the transferability of the 
findings to a context outside SSA is limited. Third, most studies were conducted in 
urban settings and recruited predominantly vertically infected participants. Therefore, 
the findings cannot be extrapolated to ALHIV residing in rural locations or 
horizontally infected ALHIV, highlighting the need for further research in those areas.  
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While this study reveals a complex picture of barriers and facilitators for ALHIV 
adherence, there is a common thread between them, which suggests possible 
benefits in shifting public health policy. The major barriers to adherence all stem from 
tensions between ALHIV and their HIV-negative peers and adults. Stigma, the need 
for secrecy, disclosure challenges, depression, religious beliefs and problematic 
intimate relationships all relate to wider societal attitudes to HIV.  
By contrast, all the facilitators mentioned, and interventions built around them, 
such as caregiver or peer group support, are directed only at ALHIV. While they may 
help mitigate the perceived wider societal attitudes, they are not going to 
fundamentally change the situation. Indeed, many interventions and attitudes of both 
healthcare workers99 and caregivers have tended to increase this division between 
ALHIV and HIV-negative peers.56    
Previous HIV campaigns100,101 using fear and morality about sex as prevention 
messages contributed to the current scenario.  
Today, ALHIV and their HIV-negative peers still receive very different health 
messages. ALHIV often first learn about HIV at schools which push a moralistic fear-
based message to frighten adolescents into abstention.59 They face a crisis when 
they learn their HIV status which is overcome with a completely different positive 
message in peer support groups. The evidence of this review strongly suggests that 
culturally-appropriate, large-scale campaigns, also aimed at schools, including 
religious authorities, could change attitudes in the wider society and create greater 
acceptance of ALHIV. A film produced by Picturing Health102 will highlight the findings 
of this review and aid in guiding researchers, policy-makers and healthcare workers 
involved with ALHIV.    
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Table 1. Study characteristics (N = 11)        
  
Reference Country, 
Setting 
Type of study 
 
Study population  
 
Study aim 
Ankrah et 
al., 201657 
Ghana,  
urban hospital 
A qualitative cross-sectional study using semi-structured interviews 
 
Time of study not included; over a period of 6 weeks 
Age 14-19 years, Mean age 16.3; 2 groups: 
12-15 years (N = 8) and 16-19 years (N = 11),  
63% female, N = 19  
To identify facilitators and barriers to 
ART adherence among adolescents  
Cluver et 
al., 201553 
South Africa, 
39 urban and rural 
health facilities 
A cross-sectional study: Quantitative interviews used standardised 
questionnaires and clinic records. Qualitative approach: 18 months of 
in-depth interviews, focus group discussions and participant 
observations. Time of study: 2013 
Age 10-19 years (10-14 years (N = 465),  
15-19 years (N = 216)), 52% female 
N = 684 
Caregivers and healthcare workers included 
To examine associations between 
adolescents’ knowledge of HIV status 
and ART adherence  
Denison et 
al., 201558 
Zambia,  
2 urban  hospitals 
Qualitative: In-depth interviews 
 
Time of study: from December 2011 to February 2012 
Age 15-18 years, 50% female 
N = 32 and 23 caregivers (19 female, 4 male) 
To explore ART adherence from 
experience of older ALHIV (15-18 
years) and adult caregivers in Zambia 
Fetzer et 
al., 201126 
Congo 
(Democratic 
Republic),  
urban hospital 
Qualitative: In-depth interviews with 20 HIV disclosed and non-
disclosed children and their caregivers 
 
Time of study: not reported 
Age 8-17 years  8-11years (N = 5),  
12-15years (N = 11), 16-18 (N = 4)). 
 > 50% aged 10-19 years, 60% female. N = 40 
(20 children, 20 caregivers: 25-63 years, 13 
females) 
To assess barriers and facilitators of 
ART adherence  
Gross et 
al., 201552 
Zimbabwe,  
2 urban low-
income clinics 
Quantitative: Cross-sectional questionnaire  
Time of study: not reported 
Age 10-19 years, Median age: 15.5, 61% 
female  
N = 262 
To identify risk/protective factors for 
non-adherence in adolescents  
Kawuma 
et al., 
201434 
Uganda, 
4 urban research 
centres  
Qualitative in-depth interviews 
Time of study: July 2011 to November 2012 
Age 11-13 years, 46% female 
N = 26 
Caregivers and healthcare workers included 
To examine reasons for non-adherence 
to ART among children and why they 
may not report non-adherence 
Kunap-
areddy et 
al., 201424 
Kenya,  
1 rural health 
centre and  1 
urban clinic 
Qualitative design: 3 focus group discussions and 3 individual semi-
structured interviews 
Time of study: March to November 2007 
Age 10-16 years, Mean age: 13.2, 48% female 
N = 23 
To identify key factors contributing to 
ART adherence  
Mavhu et 
al., 201356 
 
Zimbabwe,  
urban clinic  
Mixed methods: Use of a quantitative questionnaire and qualitative 
data through in-depth interviews (N = 10), 3 focus group discussions 
and 16 life history narratives; involved youth researchers 
Time of study: between August and September 2009 
Age 15-18 years, Median age: 14, 59% female 
N = 229, all members of support group.  
Care givers, healthcare workers and 
community members included 
To describe lived experiences of young 
people with HIV  
Mutumba 
et al., 
201554 
Uganda,  
urban hospital 
Qualitative in-depth interviews 
Time of study: between August and November 2011 
Age 13-19 years, Mean age: 16.9,  
53% female  
N = 38 
To identify psychosocial challenges and 
coping strategies among perinatal HIV 
infected adolescents  
Mutwa et 
al., 201327 
Rwanda,  
urban clinic 
Qualitative: Role-plays, focus group discussions, in-depth interviews 
Time of study: October to November 2010 
Age 12-21 years, Median age: 17, 45% female 
N = 42; a selection caregivers included 
To understand barriers to adherence for 
Rwandan adolescents 
Nabukee-
ra-Barungi 
et al., 
201537 
Uganda, 
30 urban and rural 
health facilities 
from 10 districts  
Mixed methods: Focus group discussions and in-depth interviews with 
adolescents, key informant interviews with various stakeholders. 
Retrospective records review to extract the last recorded adherence 
level. Time of study: December 2013 to February 2014 
Age 10-19 years, 63% female 
N = 1824 
Caregivers and stakeholders included 
To explore barriers and facilitators of 
adherence to ART among adolescents  
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Table 2. Factors impacting ART adherence according to themes (Summary qualitative and quantitative studies)  
 
Themes Barriers  Facilitators 
 
 
 
Patient related 
factors  
 
Stigma, forgetfulness, not knowing the reason why taking the drugs/late 
disclosure, poverty (lack of food, lack of money for transport to health facility), 
secrecy (covert storage, fear of being seen by others when taking the medicine), 
treatment fatigue, depression/frustration/isolation, delaying doses (due to 
travelling, school or work), lack of disclosure to other family members, religious 
belief (myths and misconceptions), faith healing, religious fasting, refusal to take 
drugs, substance use (alcohol, marijuana), older age (>15 or 16 years), 
interpersonal conflicts, non-acceptance of HIV status, non-disclosure to peers or 
partners, male gender, self-image/identity/peer-pressure, perceived positive 
outcome (patient feels healthy/cured), duration on ART (<1 year and <3 years) 
 
 
Adolescents’ knowledge of HIV status (best before age 
12), use of reminders (watches, clocks and phone 
alarms), integration of ART into daily routine, religious 
belief/faith, knowledge about disease, desire to be 
physically healthy/normal, belief that medication helps, 
self-motivation, perceived positive outcomes, keeping 
medicine at same spot, positive experiences with 
disclosure, log keeping 
 
Medication related 
factors 
 
 
ART side-effects (especially on empty stomach), pill burden/quantity, pill size, 
palatability, smell, colour, mistrust of medication 
 
Tablets are easier to carry than syrups 
 
 
Caregiver related 
factors 
 
Lack of caregiver assistance (adult supervision), late disclosure, Institutional 
barriers (boarding schools – lack of privacy), lack of privacy at home, lack of 
caregiver accompanying to clinic, domestic discrimination, strategies to induce 
fear (social censure, illness or death) during disclosure process 
 
 
Caregiver support (reminding to take medicine,  
accompanying to the clinic), early disclosure to 
adolescent (prior to age 12) and disclosure to other 
family members, having other family members on ART, 
caregiver understanding importance of adherence, 
assistance of 2 or more caregivers, psychosocial support 
for caregivers, interventions that involve caregivers 
 
 
Health system 
related factors 
 
Inconvenient clinic appointment times, longer travel time to clinic, long waiting 
time at clinic, repeated missed clinic appointments, rural health facilities, private 
health facilities, health centres 
 
Peer support groups, (psychosocial) support from 
healthcare providers, counseling, scheduling clinic visits 
during school holidays, short waiting time, telephone 
calls or text messages from health facilities, hospital 
care (vs health centre), short travel time to clinic, 
provision of food and transport   
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Table 3. Most emergent facilitators and barriers associated with ART 
adherence among ALHIV in SSA     
 
Patient-related factors Medication-related 
factors 
Caregiver-related 
factors 
Health-system related 
factors 
 
Facilitators 
(N=12) 
 
Barriers 
(N=23) 
 
Facilitators 
(N=1) 
 
Barriers 
(N=8) 
 
Facilitators 
(N=8) 
 
Barriers 
(N=6) 
 
Facilitators 
(N=7) 
 
Barriers 
(N=7) 
 
Knowledge of 
HIV status 
(N=5)  
Use of 
reminders 
(N=4)  
Integration of 
ART into the 
daily routine 
(N=3)  
Knowledge 
about the 
disease (N=2) 
Belief that the 
medication 
helps (N=2) 
Desire to be 
healthy/normal 
(N=2) 
Religious 
beliefs (N=1)   
 
Stigma 
(N=9) 
Forgetful-
ness (N=7) 
Secrecy 
(N=5) 
Not 
knowing 
the reason 
for taking 
the drugs 
(N=5)  
Treatment 
fatigue 
(N=5) 
Poverty 
(N=5) 
Depression 
(N=4) 
Delaying 
doses 
(N=4)  
Non-
disclosure 
to other 
family 
members 
(N=3) 
Religious 
beliefs 
(N=3) 
Intimate 
relation-
ships (N=2) 
 
Tablets 
(N=1) 
 
Drug side 
effects 
(N=8)  
Pill burden 
(N=5) 
Pill size 
(N=4) 
Palatability 
(N=3)  
 
 
Caregiver 
support 
(N=6)  
Early 
disclosure 
(N=1)  
Disclosure to 
other family 
members 
(N=1)  
Having two 
or more 
caregivers 
(N=1)  
Other family 
members on 
ART (N=1) 
 
Lack of 
assistan-
ce (N=7)  
Late 
disclosure 
(N=2)  
Lack of 
privacy at 
home and 
at 
boarding 
schools 
(N=2) 
 
 
Peer support 
groups (N=6)  
Support from 
healthcare 
workers 
(N=4)  
Counselling 
(N=2) 
 
Inconve-
nient clinic 
appoint-
ment time 
(N=1)  
Distance to 
the health 
facility 
(N=1)  
Long 
waiting 
times (N=1) 
Repeated 
missed 
appoint-
ments 
(N=1)  
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Supplementary online resource: Identification of the main concepts 
 
  Concept 
 
Alternative keywords 
 
 Population 
 
(Adolescent) OR (Adolescents) OR (Adolescence) OR (Adolescen*) OR (Youth) OR (Youths) 
OR (Teen*) OR (Teenager) OR (Teenagers) OR (Juvenile) OR (Juveniles) OR (Minor) OR 
(Minors) OR (Young person) OR (Young persons) OR (Child*) OR (Child) OR (Children) OR 
(Paediatric) OR (Pediatric) 
 
(HIV) OR (HIV 1) OR (HIV-1) OR (HIV 2) OR (HIV-2) OR (HIV infection) OR (HIV infected) 
OR (HIV positive) OR (HIV-positive) OR (Human Immunodeficiency Virus) OR (Human 
Immunodeficiency Viruses) OR (Human Immuno-Deficiency Virus) OR (Human Immuno-
Deficiency Viruses) OR (AIDS Virus) OR (AIDS Viruses) OR (Acquired Immune Deficiency 
Syndrome Virus) OR (Acquired Immune Deficiency Syndrome Viruses) OR (Acquired 
Immunodeficiency Syndrome Virus) OR (Acquired Immunodeficiency Syndrome Viruses) 
 
(Sub Saharan Africa) OR (Sub-Saharan Africa) OR (SSA) OR (Africa South of the Sahara) 
 
Intervention 
 
(ART) OR (Anti-retroviral treatment) OR (HAART) OR (Highly active antiretroviral therapy) 
OR (cART) OR (Combination antiretroviral therapy) 
 
Outcome  
 
(Adherence) OR (Compliance) OR (Retention) OR (Viral load) OR (VL)  
 
 
 
 
 
 
 
 
 
